The TRPV4 2 cation channel, a member of the TRP vanilloid subfamily, is expressed in a broad range of tissues where it participates in the generation of a Ca 2ϩ signal and/or depolarization of the membrane potential (1). TRPV4 participation in osmo-and mechanotransduction (1, 2) contributes to important functions including cellular (3, 4) and systemic volume homeostasis (5, 6), arterial dilation (7,8), nociception (9), epithelial hydroelectrolyte transport (10, 11), bladder voiding (12), and ciliary beat frequency regulation (13)(14)(15). TRPV4 also responds to temperature (16,17), endogenous arachidonic acid (AA) metabolites (18), and phorbol esters including the inactive 4␣-phorbol 12,13-didecanoate (4␣PDD) (19,20) and participates in receptor-operated Ca 2ϩ entry (15), thus showing multiple modes of activation.TRPV4 channel activity can be sensitized by co-application of different stimuli (9,21,22) or participation of different cell signaling pathways (14), suggesting the presence of different regulatory sites. In this sense, several proteins have been proposed to modulate TRPV4 subcellular localization and/or function: microtubuleassociated protein 7 (23), calmodulin (CaM, (24)), with no lysine protein kinases (25), and PACSIN3 (26). We have also recently reported a close functional and physical interaction between the inositol trisphosphate receptor 3 (IP 3 R3) and TRPV4 that sensitizes the latter to the mechano-and osmotransducing messenger 5Ј-6Ј-epoxieicosatrienoic acid (EET) (14).In this study, we reveal that IP 3 -mediated sensitization of TRPV4 to EET requires IP 3 R3 binding to TRPV4 and identify the IP 3 R3-binding site in a C-terminal region of the TRPV4 that coincides with a previously described CaM-binding site (24). Besides, our study has provided further evidence of the importance of the TRPV4 N terminus in channel gating as deletion of a proline-rich domain prevents channel activation by different stimuli despite correct localization and oligomerization.
EXPERIMENTAL PROCEDURESGeneration of TRPV4 Mutants-TRPV4 mutations were generated by site-directed mutagenesis (QuikChange II XL site-directed mutagenesis kit, Stratagene) deleting: 13 amino acids (positions 132-144) to generate the mutation lacking the N-terminal PRD domain (TRPV4-⌬PRD); 20 amino acids (positions 812-831) for the mutation lacking the calmodulinbinding domain (TRPV4-⌬CaM); and the last 4 amino acids of the channel (positions 868 -871) for the mutation lacking the C-terminal PDZ domain (TRPV4-⌬DAPL). All TRPV4 constructs were tagged with YFP (or cyan fluorescent protein) at the C terminus, and sequences were verified by PCR.Cell Transfection-HEK293 and HeLa cells were transiently transfected with ExGen500 (Fermentas MBI) using 8 eq of polyethyl enimine together with 3 g of cDNA of the following plasmids: 1.5 g of rat pcDNA3-IP 3 R3 plasmid and 1.5 g of human TRPV4-YPF plasmids, WT, or mutants. Cells were cultured from 24 to 48 h before use.Confocal Imaging-HeLa cells transiently transfected with WT and TRPV4 mutants were fixed w...